Myef2: A Protein Targeted for Drug Development (G50804)

Target Name: MYEF2

NCBI ID: G50804

MYEF2

Myef2: A Protein Targeted for Drug Development

Myef2 (HsT18564) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the Myosin regulatory protein (Mycp) family and is involved in the regulation of muscle contraction and relaxation.

Recent studies have identified Myef2 as a potential drug target in the treatment of various diseases, including heart failure, hypertension, and neurodegenerative disorders. Myef2 has also been shown to play a role in the development and progression of certain diseases, such as cancer.

One of the key functions of Myef2 is its role in the regulation of muscle contractions. Muscle contractions are critical for many physiological functions, such as movement and maintaining posture. Myef2 plays a role in the regulation of muscle contractions by interacting with the muscle protein troponin.

In addition to its role in muscle regulation, Myef2 has also been shown to have a variety of other functions. For example, it has been shown to play a role in the regulation of cell proliferation and differentiation, as well as in the regulation of cellular signaling pathways.

Despite its potential as a drug target, much more research is needed to fully understand the role of Myef2 in various diseases. Currently, there are no FDA-approved drugs that specifically target Myef2.

In conclusion, Myef2 is a protein that has the potential to be a drug target for a variety of diseases. Further research is needed to fully understand its role and to develop effective treatments.

Protein Name: Myelin Expression Factor 2

Functions: Transcriptional repressor of the myelin basic protein gene (MBP). Binds to the proximal MB1 element 5'-TTGTCC-3' of the MBP promoter. Its binding to MB1 and function are inhibited by PURA (By similarity)

The "MYEF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYEF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets